Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
diabetes mellitus type 2/obesidad
El enlace se guarda en el portapapeles.
Página 1 desde 390 resultados
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to a method for treating the metabolic syndrome, obesity, prediabetes or metabolic conditions thereof, or Type 2 diabetes, and more particularly to a method for treating the metabolic syndrome, obesity,
Polypeptide for obesity and type II diabetes mellitus
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to non-insulin dependent diabetes mellitus (NIDDM) (type II) and obesity, and specifically to a novel Trp64Arg mutation in the .beta.3-adrenergic receptor that increases susceptibility to obesity and type II
Susceptibility gene for obesity and type II diabetes mellitus
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to non-insulin dependent diabetes mellitus (NIDDM) (type II) and obesity, and specifically to a novel Trp64Arg mutation in the .beta.3-adrenergic receptor that increases susceptibility to obesity and type II
Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The entireties of all of these priority applications are hereby incorporated by reference.
BACKGROUND OF THE INVENTION
Obesity is an epidemic in the U.S. with a prevalence of about 20 percent. Annual U.S. healthcare costs associated with obesity are estimated to exceed $200 billion dollars. Obesity
Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from Prevotella
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION
A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, herein the strain is
Animal model for type 2 diabetes and obesity
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
PRIORITY
This application corresponds to the U.S. national phase of International Application No. PCT/EP2013/072772, filed Oct. 31, 2013, which, in turn, claims priority to European Patent Application No. 12.007446.3 filed Oct. 31, 2012, the contents of which are incorporated by reference herein in
Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Apr. 5, 2019, is named 33863-42455_US_SL.txt and is 321,948 bytes in size.
BACKGROUND OF THE INVENTION
The
ENPP1 (PC-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The present invention is directed to a method for determining if a subject is at increased risk to develop obesity or pathology related to obesity by determining the presence of a haplotype comprising three specific SNPs in a DNA or RNA sample of this subject and/or an elevated serum ENPP1 protein
Systems and methods for treating obesity and type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The present invention relates to the field of obesity and diabetes and more specifically to minimally invasive systems and methods for controlling or treating obesity and/or type 2 diabetes.
Obesity is one of the leading preventable causes of death worldwide and has
Systems and methods for treating obesity and type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The present invention relates to the field of obesity and diabetes and more specifically to minimally invasive systems and methods for controlling or treating obesity and/or type 2 diabetes.
Obesity is one of the leading preventable causes of death worldwide and has
Systems and methods for treatment of obesity and type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The present invention relates to the field of obesity and diabetes and more specifically to minimally invasive systems and methods for controlling or treating obesity and/or type 2 diabetes.
Obesity is one of the leading preventable causes of death worldwide and has
Systems and methods for treatment of obesity and type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The present invention relates to the field of obesity and diabetes and more specifically to minimally invasive systems and methods for controlling or treating obesity and/or type 2 diabetes.
Obesity is one of the leading preventable causes of death worldwide and has
Systems and methods for treatment of obesity and type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The present invention relates to the field of obesity and diabetes and more specifically to minimally invasive systems and methods for controlling or treating obesity and/or type 2 diabetes.
Obesity is one of the leading preventable causes of death worldwide and has
Systems and methods for treatment of obesity and type 2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The present invention relates to the field of obesity and diabetes and more specifically to minimally invasive systems and methods for controlling or treating obesity and/or type 2 diabetes.
Obesity is one of the leading preventable causes of death worldwide and has
Genes and markers in type 2 diabetes and obesity
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
The term diabetes mellitus (DM) (ICD/10 codes E10-E14) describes several syndromes of abnormal carbohydrate metabolism that are characterized by hyperglycemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of
La base de datos de hierbas medicinales más completa respaldada por la ciencia
- Funciona en 55 idiomas
- Curas a base de hierbas respaldadas por la ciencia
- Reconocimiento de hierbas por imagen
- Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
- Leer publicaciones científicas relacionadas con su búsqueda
- Buscar hierbas medicinales por sus efectos.
- Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.
Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.
